|
1）Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2006; 114: e84-231
|
|
|
|
2）Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease; The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007; 28: 230-68
|
|
|
|
|
|
3）Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol. 2007; 50: 2018-9
|
|
|
|
|
|
4）Gurvitch R, Wood DA, Tay EL, et al. Trans-catheter aortic valve implantation. Durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation. 2010; 122: 1319-27
|
|
|
|
|
|
5）Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007; 50: 69-76
|
|
|
|
|
|
6）Feldman T, Kar S, Rinaldi M, et al; EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol. 2009; 54: 686-94
|
|
|
|
|
|
7）Webb JG, Wood DA, Ye J, et al. Transcatheter valve-in-valve implantation for failed biopros-thetic heart valves. Circulation. 2010; 121: 1848-57
|
|
|
|
|
|
8）Thomas MR, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010; 122: 62-9
|
|
|
|
|
|
9）Leon MB, Smith CR, Mack M, et al. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363: 1597-607
|
|
|
|
|
|
10）Kodali SK, Williams MR, Smith CR, et al; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012; 366: 1686-95
|
|
|
|
|
|
11）Linke A, Gerckens U, ADVANCE Investigators. Treatment of High Risk Aortic Stenosis Patients with Transcatheter Medtronic CoreValve Implantation. Presentation in ACC 2012
|
|
|
|
|
|
12）Whitlow PL, Feldman T, Pedersen WR, et al; EVEREST II Investigators. Acute and 12-month results with catheter-based mitral valve leaflet repair; The EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol. 2012; 59: 130-9
|
|
|
|
|